HomeZTS • NYSE
add
Zoetis Inc
Previous close
$167.23
Day range
$166.95 - $171.69
Year range
$144.80 - $201.92
Market cap
76.34B USD
Avg Volume
4.13M
P/E ratio
32.95
Dividend yield
1.03%
Primary exchange
NYSE
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 2.19B | 9.50% |
Operating expense | 746.00M | 9.06% |
Net income | 599.00M | 8.51% |
Net profit margin | 27.35 | -0.91% |
Earnings per share | 1.38 | 5.34% |
EBITDA | 905.00M | 6.72% |
Effective tax rate | 19.81% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.04B | -3.22% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 4.99B | — |
Shares outstanding | 457.87M | — |
Price to book | 15.34 | — |
Return on assets | — | — |
Return on capital | 16.93% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 599.00M | 8.51% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
Founded
1952
Headquarters
Website
Employees
14,100